ArticleJAAD case reports2019
Linear IgA bullous dermatosis successfully treated with omalizumab: A case report.
Article in JAAD case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.
- Updates in the Diagnosis and Management of Linear IgA Disease: A Systematic Review.Medicina (Kaunas, Lithuania) · 2021Pooled it
- Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database.Journal of clinical medicine · 2024Article
- Successful treatment of linear immunoglobulin A bullous dermatosis with dupilumab in a pediatric patient.JAAD case reports · 2023Article
- Management Options for Linear Immunoglobulin A (IgA) Bullous Dermatosis: A Literature Review.Cureus · 2023Review
- Pruritogens in pemphigoid diseases: Possible therapeutic targets for a burdensome symptom.The Journal of dermatology · 2023Review
- Linear IgA bullous dermatosis with Koebner phenomenon in a liver transplant patient.Postepy dermatologii i alergologii · 2022Article
- Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report.Clinical case reports · 2022Article
- A Case of Linear IgA Bullous Dermatosis Successfully Treated with Omalizumab.Indian journal of dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.